{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:17:38Z","timestamp":1762543058440,"version":"3.40.3"},"publisher-location":"Cham","reference-count":112,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030504939"},{"type":"electronic","value":"9783030504946"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_208","type":"book-chapter","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T08:06:31Z","timestamp":1559808391000},"page":"507-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Disorders of Puberty: Pharmacotherapeutic Strategies for Management"],"prefix":"10.1007","author":[{"given":"Margaret","family":"Zacharin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"issue":"1","key":"208_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1515\/jpem-2017-0280","volume":"31","author":"A Albrecht","year":"2018","unstructured":"Albrecht A, Penger T, Marx M, Hirsch K, Dorr HG (2018) Short-term adverse effects of testosterone used for priming in prepubertal boys before growth hormone stimulation test. J Pediatr Endocrinol Metab 31(1):21\u201324. \n                https:\/\/doi.org\/10.1515\/jpem-2017-0280","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"208_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2265.2007.03160.x","volume":"69","author":"MQ Almeida","year":"2008","unstructured":"Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR et al (2008) Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol 69(1):93\u201398. \n                https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03160.x","journal-title":"Clin Endocrinol"},{"issue":"1","key":"208_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1677\/JOE-10-0006","volume":"207","author":"A Bajpai","year":"2010","unstructured":"Bajpai A, Simm PJ, McPherson SJ, Russo VC, Azar WJ, Wark JD et al (2010) Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia. J Endocrinol 207(1):27\u201334. \n                https:\/\/doi.org\/10.1677\/JOE-10-0006","journal-title":"J Endocrinol"},{"issue":"3","key":"208_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/17512433.2017.1271708","volume":"10","author":"C Bastianelli","year":"2017","unstructured":"Bastianelli C, Farris M, Rosato E, Brosens I, Benagiano G (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism. Expert Rev Clin Pharmacol 10(3):315\u2013326. \n                https:\/\/doi.org\/10.1080\/17512433.2017.1271708","journal-title":"Expert Rev Clin Pharmacol"},{"key":"208_CR5","first-page":"405","volume-title":"Testosterone, action, deficiency, substitution","author":"HM Behre","year":"2004","unstructured":"Behre HM, C W, Handelsman DJ, Nieschlag E (2004) Pharmacology of testosterone preparations. In: Testosterone, action, deficiency, substitution. Cambridge University Press, Cambridge, pp 405\u2013444"},{"issue":"Suppl 2","key":"208_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4274\/jcrpe.2017.S004","volume":"9","author":"A Bereket","year":"2017","unstructured":"Bereket A (2017) A critical appraisal of the effect of gonadotropin-releasing hormone analog treatment on adult height of girls with central precocious puberty. J Clin Res Pediatr Endocrinol 9(Suppl 2):33\u201348. \n                https:\/\/doi.org\/10.4274\/jcrpe.2017.S004","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"208_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00431-017-2898-8","volume":"176","author":"S Bertelloni","year":"2017","unstructured":"Bertelloni S, Massart F, Miccoli M, Baroncelli GI (2017) Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty: a meta-analysis. Eur J Pediatr 176(6):697\u2013704. \n                https:\/\/doi.org\/10.1007\/s00431-017-2898-8","journal-title":"Eur J Pediatr"},{"issue":"1\u20135","key":"208_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0960-0760(01)00050-4","volume":"76","author":"AS Bhatnagar","year":"2001","unstructured":"Bhatnagar AS, Brodie AM, Long BJ, Evans DB, Miller WR (2001) Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J Steroid Biochem Mol Biol 76(1\u20135):199\u2013202","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"208_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/S0004-27302008000100005","volume":"52","author":"VN Brito","year":"2008","unstructured":"Brito VN, Latronico AC, Arnhold IJ, Mendonca BB (2008) Update on the etiology, diagnosis and therapeutic management of sexual precocity. Arq Bras Endocrinol Metabol 52(1):18\u201331","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"208_CR10","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1542\/peds.2008-1783","volume":"123","author":"JC Carel","year":"2009","unstructured":"Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group et al (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4):e752\u2013e762. \n                https:\/\/doi.org\/10.1542\/peds.2008-1783","journal-title":"Pediatrics"},{"issue":"5","key":"208_CR11","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2016.12.019","volume":"216","author":"SW Champaloux","year":"2017","unstructured":"Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ (2017) Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol 216(5):489.e1\u2013489.e7. \n                https:\/\/doi.org\/10.1016\/j.ajog.2016.12.019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"208_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40618-017-0726-7","volume":"41","author":"L Chioma","year":"2018","unstructured":"Chioma L, Papucci G, Fintini D, Cappa M (2018) Use of testosterone gel compared to intramuscular formulation for puberty induction in males with constitutional delay of growth and puberty: a preliminary study. J Endocrinol Investig 41(2):259\u2013263. \n                https:\/\/doi.org\/10.1007\/s40618-017-0726-7","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"208_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ajo.12595","volume":"57","author":"I Chuah","year":"2017","unstructured":"Chuah I, McRae A, Matthews K, Maguire AM, Steinbeck K (2017) Menstrual management in developmentally delayed adolescent females. Aust N Z J Obstet Gynaecol 57(3):346\u2013350. \n                https:\/\/doi.org\/10.1111\/ajo.12595","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"Suppl 1","key":"208_CR14","first-page":"695","volume":"13","author":"M Cisternino","year":"2000","unstructured":"Cisternino M, Arrigo T, Pasquino AM, Tinelli C, Antoniazzi F, Beduschi L et al (2000) Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab 13(Suppl 1):695\u2013701","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"208_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/jcem-29-4-558","volume":"29","author":"MG Crane","year":"1969","unstructured":"Crane MG, Harris JJ (1969) Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents. J Clin Endocrinol Metab 29(4):558\u2013562. \n                https:\/\/doi.org\/10.1210\/jcem-29-4-558","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"208_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/jcem-26-12-1403","volume":"26","author":"MG Crane","year":"1966","unstructured":"Crane MG, Heitsch J, Harris JJ, Johns VJ Jr (1966) Effect of ethinyl estradiol (estinyl) on plasma renin activity. J Clin Endocrinol Metab 26(12):403\u2013406","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"208_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJMcp1608736","volume":"376","author":"KM Curtis","year":"2017","unstructured":"Curtis KM, Peipert JF (2017) Long-acting reversible contraception. N Engl J Med 376(5):461\u2013468. \n                https:\/\/doi.org\/10.1056\/NEJMcp1608736","journal-title":"N Engl J Med"},{"issue":"3","key":"208_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000435881","volume":"84","author":"GBC de Passone","year":"2015","unstructured":"de Passone GBC, Kuperman H, Cabral de Menezes-Filho H, Spassapan Oliveira Esteves L, Lana Obata Giroto R, Damiani D (2015) Tamoxifen improves final height prediction in girls with McCune-Albright syndrome: a long follow-up. Horm Res Paediatr 84(3):184\u2013189. \n                https:\/\/doi.org\/10.1159\/000435881","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"208_CR19","doi-asserted-by":"publisher","first-page":"364.e1","DOI":"10.1016\/j.ajog.2016.12.024","volume":"216","author":"JT Diedrich","year":"2017","unstructured":"Diedrich JT, Klein DA, Peipert JF (2017) Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol 216(4):364.e1\u2013364.e2. \n                https:\/\/doi.org\/10.1016\/j.ajog.2016.12.024","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"208_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ijgo.12455","volume":"141","author":"MV Dragoman","year":"2018","unstructured":"Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME (2018) A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet 141(3):287\u2013294. \n                https:\/\/doi.org\/10.1002\/ijgo.12455","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"208_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/sm2.50","volume":"3","author":"AA Dwyer","year":"2015","unstructured":"Dwyer AA, Quinton R, Pitteloud N, Morin D (2015) Psychosexual development in men with congenital hypogonadotropic hypogonadism on long-term treatment: a mixed methods study. Sex Med 3(1):32\u201341. \n                https:\/\/doi.org\/10.1002\/sm2.50","journal-title":"Sex Med"},{"issue":"6","key":"208_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/and.12493","volume":"48","author":"M Efros","year":"2016","unstructured":"Efros M, Carrara D, Neijber A (2016) The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies. Andrologia 48(6):637\u2013645. \n                https:\/\/doi.org\/10.1111\/and.12493","journal-title":"Andrologia"},{"issue":"5","key":"208_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-16-0526","volume":"175","author":"A Estrada","year":"2016","unstructured":"Estrada A, Boyce AM, Brillante BA, Guthrie LC, Gafni RI, Collins MT (2016) Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome. Eur J Endocrinol 175(5):477\u2013483. \n                https:\/\/doi.org\/10.1530\/EJE-16-0526","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"208_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0022-3476(03)00128-8","volume":"143","author":"EA Eugster","year":"2003","unstructured":"Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, Pescovitz OH, McCune-Albright Study G (2003) Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 143(1):60\u201366. \n                https:\/\/doi.org\/10.1016\/S0022-3476(03)00128-8","journal-title":"J Pediatr"},{"issue":"10","key":"208_CR25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1080\/17512433.2017.1356718","volume":"10","author":"M Farris","year":"2017","unstructured":"Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G (2017) Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. Effects on hemostasis. Expert Rev Clin Pharmacol 10(10):1129\u20131144. \n                https:\/\/doi.org\/10.1080\/17512433.2017.1356718","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"208_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1515\/jpem-2016-0219","volume":"30","author":"JA Ferris","year":"2017","unstructured":"Ferris JA, Geffner ME (2017) Are aromatase inhibitors in boys with predicted short stature and\/or rapidly advancing bone age effective and safe? J Pediatr Endocrinol Metab 30(3):311\u2013317. \n                https:\/\/doi.org\/10.1515\/jpem-2016-0219","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"208_CR27","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2006-2350","volume":"92","author":"P Feuillan","year":"2007","unstructured":"Feuillan P, Calis K, Hill S, Shawker T, Robey PG, Collins MT (2007) Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab 92(6):2100\u20132106. \n                https:\/\/doi.org\/10.1210\/jc.2006-2350","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"208_CR28","first-page":"133","volume":"4","author":"K Fotherby","year":"1982","unstructured":"Fotherby K (1982) Pharmacokinetics of ethynyloestradiol in humans. Methods Find Exp Clin Pharmacol 4(2):133\u2013141","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"5","key":"208_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0010-7824(80)90105-5","volume":"22","author":"K Fotherby","year":"1980","unstructured":"Fotherby K, Koetsawang S, Mathrubutham M (1980) Pharmacokinetic study of different doses of Depo Provera. Contraception 22(5):527\u2013536","journal-title":"Contraception"},{"issue":"10","key":"208_CR30","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1093\/humrep\/der224","volume":"26","author":"IS Fraser","year":"2011","unstructured":"Fraser IS, Romer T, Parke S, Zeun S, Mellinger U, Machlitt A, Jensen JT (2011) Effective treatment of heavy and\/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind phase III trial. Hum Reprod 26(10):2698\u20132708. \n                https:\/\/doi.org\/10.1093\/humrep\/der224","journal-title":"Hum Reprod"},{"issue":"3","key":"208_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/adc.55.3.218","volume":"55","author":"G Geere","year":"1980","unstructured":"Geere G, Jones J, Atherden SM, Grant DB (1980) Plasma androgens after a single oral dose of testosterone undecanoate. Arch Dis Child 55(3):218\u2013220","journal-title":"Arch Dis Child"},{"issue":"7","key":"208_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/bjc.2011.58","volume":"104","author":"J Geisler","year":"2011","unstructured":"Geisler J (2011) Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole \u2013 of clinical importance? Br J Cancer 104(7):1059\u20131066. \n                https:\/\/doi.org\/10.1038\/bjc.2011.58","journal-title":"Br J Cancer"},{"issue":"8","key":"208_CR33","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/bjc.1996.531","volume":"74","author":"J Geisler","year":"1996","unstructured":"Geisler J, King N, Dowsett M, Ottestad L, Lundgren S, Walton P et al (1996) Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer 74(8):1286\u20131291","journal-title":"Br J Cancer"},{"issue":"7","key":"208_CR34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/14656566.2018.1462337","volume":"19","author":"G Grandi","year":"2018","unstructured":"Grandi G, Farulla A, Sileo FG, Facchinetti F (2018) Levonorgestrel-releasing intra-uterine systems as female contraceptives. Expert Opin Pharmacother 19(7):677\u2013686. \n                https:\/\/doi.org\/10.1080\/14656566.2018.1462337","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"208_CR35","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1210\/jcem.80.5.7745014","volume":"80","author":"DJ Handelsman","year":"1995","unstructured":"Handelsman DJ, Turner L, Boylan LM, Conway AJ (1995) Pharmacokinetics of human follicle-stimulating hormone in gonadotropin-deficient men. J Clin Endocrinol Metab 80(5):1657\u20131663. \n                https:\/\/doi.org\/10.1210\/jcem.80.5.7745014","journal-title":"J Clin Endocrinol Metab"},{"key":"208_CR36","first-page":"249","volume-title":"Hormonal manipulation of cancer: peptide, growth factors and new (anti) steroidal agents","author":"J Happ","year":"1987","unstructured":"Happ J, Schultheiss H, Jacobi GH, Wenderoth UK, Buttensch\u00f6n K, Miesel K, Spahn H, H\u00f6r G (1987) Pharmacodynamics, pharmacokinetics and bioavailability of the prolonged LH-RH agonist decapeptyl-SR. In: Paridaens R, Klijn JMG, Foekens JA (eds) Hormonal manipulation of cancer: peptide, growth factors and new (anti) steroidal agents. Raven Press, New York, pp 249\u2013253"},{"issue":"4","key":"208_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","volume":"81","author":"Z Harel","year":"2010","unstructured":"Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R et al (2010) Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 81(4):281\u2013291. \n                https:\/\/doi.org\/10.1016\/j.contraception.2009.11.003","journal-title":"Contraception"},{"issue":"7","key":"208_CR38","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/jbmr.56","volume":"25","author":"M Hero","year":"2010","unstructured":"Hero M, Toiviainen-Salo S, Wickman S, Makitie O, Dunkel L (2010) Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty. J Bone Miner Res 25(7):1536\u20131543. \n                https:\/\/doi.org\/10.1002\/jbmr.56","journal-title":"J Bone Miner Res"},{"issue":"8","key":"208_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","volume":"88","author":"AG Herzog","year":"2017","unstructured":"Herzog AG, Mandle HB, Cahill KE, Fowler KM, Hauser WA (2017) Predictors of unintended pregnancy in women with epilepsy. Neurology 88(8):728\u2013733. \n                https:\/\/doi.org\/10.1212\/WNL.0000000000003637","journal-title":"Neurology"},{"issue":"9","key":"208_CR40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5694\/mja12.11042","volume":"197","author":"JK Hewitt","year":"2012","unstructured":"Hewitt JK, Zacharin MR (2012) Adverse effects of adult topical androgen use on children. Med J Aust 197(9):490","journal-title":"Med J Aust"},{"issue":"16","key":"208_CR41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJM198504183121604","volume":"312","author":"FJ Holland","year":"1985","unstructured":"Holland FJ, Fishman L, Bailey JD, Fazekas AT (1985) Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med 312(16):1023\u20131028. \n                https:\/\/doi.org\/10.1056\/NEJM198504183121604","journal-title":"N Engl J Med"},{"issue":"3","key":"208_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jth.12484","volume":"12","author":"HN Holmegard","year":"2014","unstructured":"Holmegard HN, Nordestgaard BG, Schnohr P, Tybjaerg-Hansen A, Benn M (2014) Endogenous sex hormones and risk of venous thromboembolism in women and men. J Thromb Haemost 12(3):297\u2013305. \n                https:\/\/doi.org\/10.1111\/jth.12484","journal-title":"J Thromb Haemost"},{"key":"208_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000438891","volume":"29","author":"S Howard","year":"2016","unstructured":"Howard S, Dunkel L (2016) Sex steroid and gonadotropin treatment in male delayed puberty. Endocr Dev 29:185\u2013197. \n                https:\/\/doi.org\/10.1159\/000438891","journal-title":"Endocr Dev"},{"issue":"2","key":"208_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11154-011-9180-6","volume":"12","author":"MM Isley","year":"2011","unstructured":"Isley MM, Kaunitz AM (2011) Update on hormonal contraception and bone density. Rev Endocr Metab Disord 12(2):93\u2013106. \n                https:\/\/doi.org\/10.1007\/s11154-011-9180-6","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"208_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.contraception.2016.10.006","volume":"95","author":"TC Jatlaoui","year":"2017","unstructured":"Jatlaoui TC, Riley HE, Curtis KM (2017) The safety of intrauterine devices among young women: a systematic review. Contraception 95(1):17\u201339. \n                https:\/\/doi.org\/10.1016\/j.contraception.2016.10.006","journal-title":"Contraception"},{"issue":"6","key":"208_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.contraception.2017.08.009","volume":"96","author":"S Kang","year":"2017","unstructured":"Kang S, Niak A, Gada N, Brinker A, Jones SC (2017) Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database. Contraception 96(6):439\u2013445. \n                https:\/\/doi.org\/10.1016\/j.contraception.2017.08.009","journal-title":"Contraception"},{"issue":"4","key":"208_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1743-6109.2011.02630.x","volume":"9","author":"JM Kaufman","year":"2012","unstructured":"Kaufman JM, Miller MG, Fitzpatrick S, McWhirter C, Brennan JJ (2012) One-year efficacy and safety study of a 1.62% testosterone gel in hypogonadal men: results of a 182-day open-label extension of a 6-month double-blind study. J Sex Med 9(4):1149\u20131161. \n                https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02630.x","journal-title":"J Sex Med"},{"issue":"2","key":"208_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000185432","volume":"47","author":"R Kauli","year":"1997","unstructured":"Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z (1997) Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 47(2):54\u201361. \n                https:\/\/doi.org\/10.1159\/000185432","journal-title":"Horm Res"},{"issue":"5","key":"208_CR49","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1210\/jc.2017-02183","volume":"103","author":"KO Klein","year":"2018","unstructured":"Klein KO, Rosenfield RL, Santen RJ, Gawlik AM, Backeljauw PF, Gravholt CH et al (2018) Estrogen replacement in turner syndrome: literature review and practical considerations. J Clin Endocrinol Metab 103(5):1790\u20131803. \n                https:\/\/doi.org\/10.1210\/jc.2017-02183","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"208_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/jcem.79.2.8045943","volume":"79","author":"GB Kletter","year":"1994","unstructured":"Kletter GB, Kelch RP (1994) Clinical review 60: effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79(2):331\u2013334. \n                https:\/\/doi.org\/10.1210\/jcem.79.2.8045943","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"208_CR51","first-page":"723","volume":"13","author":"N Lahlou","year":"2000","unstructured":"Lahlou N, Carel JC, Chaussain JL, Roger M (2000) Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab 13(Suppl 1):723\u2013737","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl 1","key":"208_CR52","first-page":"805","volume":"13","author":"Z Laron","year":"2000","unstructured":"Laron Z, Kauli R (2000) Experience with cyproterone acetate in the treatment of precocious puberty. J Pediatr Endocrinol Metab 13(Suppl 1):805\u2013810","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"208_CR53","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1210\/jcem.87.5.8481","volume":"87","author":"L Lazar","year":"2002","unstructured":"Lazar L, Kauli R, Pertzelan A, Phillip M (2002) Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab 87(5):2090\u20132094. \n                https:\/\/doi.org\/10.1210\/jcem.87.5.8481","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"208_CR54","doi-asserted-by":"publisher","first-page":"e728","DOI":"10.1542\/peds.2010-0596","volume":"126","author":"AM Lenz","year":"2010","unstructured":"Lenz AM, Shulman D, Eugster EA, Rahhal S, Fuqua JS, Pescovitz OH, Lewis KA (2010) Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics 126(3):e728\u2013e733. \n                https:\/\/doi.org\/10.1542\/peds.2010-0596","journal-title":"Pediatrics"},{"issue":"1","key":"208_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/jcem.84.1.5413","volume":"84","author":"EW Leschek","year":"1999","unstructured":"Leschek EW, Jones J, Barnes KM, Hill SC, Cutler GB Jr (1999) Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab 84(1):175\u2013178. \n                https:\/\/doi.org\/10.1210\/jcem.84.1.5413","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"208_CR56","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s40618-016-0486-9","volume":"39","author":"S Liu","year":"2016","unstructured":"Liu S, Liu Q, Cheng X, Luo Y, Wen Y (2016) Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis. J Endocrinol Investig 39(10):1167\u20131178. \n                https:\/\/doi.org\/10.1007\/s40618-016-0486-9","journal-title":"J Endocrinol Investig"},{"issue":"6A","key":"208_CR57","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0022-4731(85)90068-8","volume":"23","author":"C Longcope","year":"1985","unstructured":"Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J, Warram J (1985) The metabolism of estradiol; oral compared to intravenous administration. J Steroid Biochem 23(6A):1065\u20131070","journal-title":"J Steroid Biochem"},{"key":"208_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1749-6632.1991.tb37898.x","volume":"626","author":"T Luukkainen","year":"1991","unstructured":"Luukkainen T (1991) Levonorgestrel-releasing intrauterine device. Ann N Y Acad Sci 626:43\u201349","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"208_CR59","first-page":"718","volume":"9","author":"N Mauras","year":"2012","unstructured":"Mauras N, Torres-Santiago L, Taboada M, Santen R (2012) Estrogen therapy in Turner syndrome: does the type, dose and mode of delivery matter? Pediatr Endocrinol Rev 9(Suppl 2):718\u2013722","journal-title":"Pediatr Endocrinol Rev"},{"key":"208_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cen.13869","volume":"90","author":"N Mauras","year":"2018","unstructured":"Mauras N, Torres-Santiago L, Santen R, Mericq V, Ross J, Colon-Otero G et al (2018) Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome. Clin Endocrinol 90:155\u2013161. \n                https:\/\/doi.org\/10.1111\/cen.13869","journal-title":"Clin Endocrinol"},{"key":"208_CR61","doi-asserted-by":"publisher","first-page":"CD010888","DOI":"10.1002\/14651858.CD010888.pub2","volume":"10","author":"N McGrath","year":"2015","unstructured":"McGrath N, O\u2019Grady MJ (2015) Aromatase inhibitors for short stature in male children and adolescents. Cochrane Database Syst Rev 10:CD010888. \n                https:\/\/doi.org\/10.1002\/14651858.CD010888.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"208_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.14310\/horm.2002.1515","volume":"14","author":"MF Messina","year":"2015","unstructured":"Messina MF, Aversa T, de Sanctis L, Wasniewska M, Valenzise M, Pajno GB et al (2015) Adult height following a combined treatment of ketoconazole \u2013 cyproterone acetate \u2013 leuprolide depot in a boy with atypical McCune-Albright syndrome. Hormones (Athens) 14(2):286\u2013292. \n                https:\/\/doi.org\/10.14310\/horm.2002.1515","journal-title":"Hormones (Athens)"},{"issue":"5","key":"208_CR63","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1530\/EJE-14-0891","volume":"172","author":"T Middleton","year":"2015","unstructured":"Middleton T, Turner L, Fennell C, Savkovic S, Jayadev V, Conway AJ, Handelsman DJ (2015) Complications of injectable testosterone undecanoate in routine clinical practice. Eur J Endocrinol 172(5):511\u2013517. \n                https:\/\/doi.org\/10.1530\/EJE-14-0891","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 4","key":"208_CR64","first-page":"419","volume":"4","author":"J Mieszczak","year":"2007","unstructured":"Mieszczak J, Eugster EA (2007) Treatment of precocious puberty in McCune-Albright syndrome. Pediatr Endocrinol Rev 4(Suppl 4):419\u2013422","journal-title":"Pediatr Endocrinol Rev"},{"issue":"7","key":"208_CR65","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1210\/jc.2007-2090","volume":"93","author":"J Mieszczak","year":"2008","unstructured":"Mieszczak J, Lowe ES, Plourde P, Eugster EA (2008) The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 93(7):2751\u20132754. \n                https:\/\/doi.org\/10.1210\/jc.2007-2090","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"208_CR66","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0300-595X(86)80031-7","volume":"15","author":"JA Miller","year":"1986","unstructured":"Miller JA, Jacobs HS (1986) Treatment of hirsutism and acne with cyproterone acetate. Clin Endocrinol Metab 15(2):373\u2013389","journal-title":"Clin Endocrinol Metab"},{"issue":"10","key":"208_CR67","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.clinthera.2010.09.009","volume":"32","author":"BS Miller","year":"2010","unstructured":"Miller BS, Shukla AR (2010) Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists. Clin Ther 32(10):1749\u20131751. \n                https:\/\/doi.org\/10.1016\/j.clinthera.2010.09.009","journal-title":"Clin Ther"},{"issue":"3","key":"208_CR68","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/13685530701437510","volume":"10","author":"T Minnemann","year":"2007","unstructured":"Minnemann T, Schubert M, Hubler D, Gouni-Berthold I, Freude S, Schumann C et al (2007) A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate. Aging Male 10(3):155\u2013158. \n                https:\/\/doi.org\/10.1080\/13685530701437510","journal-title":"Aging Male"},{"issue":"6","key":"208_CR69","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4158\/EP13101.OR","volume":"19","author":"Z Nabhan","year":"2013","unstructured":"Nabhan Z, Eugster EA (2013) Hormone replacement therapy in children with hypogonadotropic hypogonadism: where do we stand? Endocr Pract 19(6):968\u2013971. \n                https:\/\/doi.org\/10.4158\/EP13101.OR","journal-title":"Endocr Pract"},{"issue":"1","key":"208_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0029-1211261","volume":"102","author":"F Neumann","year":"1994","unstructured":"Neumann F (1994) The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research. Exp Clin Endocrinol 102(1):1\u201332. \n                https:\/\/doi.org\/10.1055\/s-0029-1211261","journal-title":"Exp Clin Endocrinol"},{"issue":"2","key":"208_CR71","doi-asserted-by":"publisher","first-page":"136","DOI":"10.17458\/per.vol15.2017.nau.treatmentgirlsboys","volume":"15","author":"A Neyman","year":"2017","unstructured":"Neyman A, Eugster EA (2017) Treatment of girls and boys with McCune-Albright syndrome with precocious puberty \u2013 update 2017. Pediatr Endocrinol Rev 15(2):136\u2013141. \n                https:\/\/doi.org\/10.17458\/per.vol15.2017.nau.treatmentgirlsboys","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"208_CR72","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1530\/acta.0.0790366","volume":"79","author":"E Nieschlag","year":"1975","unstructured":"Nieschlag E, Mauss J, Coert A, Kicovic P (1975) Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol 79(2):366\u2013374","journal-title":"Acta Endocrinol"},{"issue":"3","key":"208_CR73","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000178721","volume":"7","author":"E Nieschlag","year":"1976","unstructured":"Nieschlag E, Cuppers HJ, Wiegelmann W, Wickings EJ (1976) Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men. Horm Res 7(3):138\u2013145. \n                https:\/\/doi.org\/10.1159\/000178721","journal-title":"Horm Res"},{"key":"208_CR74","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bone.2015.12.054","volume":"84","author":"JW Nieves","year":"2016","unstructured":"Nieves JW, Ruffing JA, Zion M, Tendy S, Yavorek T, Lindsay R, Cosman F (2016) Eating disorders, menstrual dysfunction, weight change and DMPA use predict bone density change in college-aged women. Bone 84:113\u2013119. \n                https:\/\/doi.org\/10.1016\/j.bone.2015.12.054","journal-title":"Bone"},{"key":"208_CR75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000438892","volume":"29","author":"E Norjavaara","year":"2016","unstructured":"Norjavaara E, Ankarberg-Lindgren C, Kristrom B (2016) Sex steroid replacement therapy in female hypogonadism from childhood to young adulthood. Endocr Dev 29:198\u2013213. \n                https:\/\/doi.org\/10.1159\/000438892","journal-title":"Endocr Dev"},{"issue":"2","key":"208_CR76","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1210\/jcem.84.2.5430","volume":"84","author":"MR Palmert","year":"1999","unstructured":"Palmert MR, Malin HV, Boepple PA (1999) Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 84(2):415\u2013423. \n                https:\/\/doi.org\/10.1210\/jcem.84.2.5430","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"208_CR77","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1210\/jcem.80.2.7852518","volume":"80","author":"D Paul","year":"1995","unstructured":"Paul D, Conte FA, Grumbach MM, Kaplan SL (1995) Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5\u00a0years. J Clin Endocrinol Metab 80(2):546\u2013551. \n                https:\/\/doi.org\/10.1210\/jcem.80.2.7852518","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"208_CR78","first-page":"1289","volume":"106","author":"MH Perrin","year":"1980","unstructured":"Perrin MH, Rivier JE, Vale WW (1980) Radioligand assay for gonadotropin-releasing hormone: relative potencies of agonists and antagonists. Endocrinology 106(4):1289\u20131296","journal-title":"Endocrinology"},{"issue":"7","key":"208_CR79","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1210\/jc.2003-032069","volume":"89","author":"S Piippo","year":"2004","unstructured":"Piippo S, Lenko H, Kainulainen P, Sipila I (2004) Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab 89(7):3241\u20133247. \n                https:\/\/doi.org\/10.1210\/jc.2003-032069","journal-title":"J Clin Endocrinol Metab"},{"key":"208_CR80","doi-asserted-by":"publisher","unstructured":"Ponce OJ, Spencer-Bonilla G, Alvarez-Villalobos N, Serrano V, Singh-Ospina N, Rodriguez-Gutierrez R et al (2018) The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Endocrinol Metab. \n                https:\/\/doi.org\/10.1210\/jc.2018-00404","DOI":"10.1210\/jc.2018-00404"},{"issue":"4","key":"208_CR81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2230.1990.tb02089.x","volume":"15","author":"ID Ramsay","year":"1990","unstructured":"Ramsay ID, Rushton DH (1990) Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia. Clin Exp Dermatol 15(4):277\u2013281","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"208_CR82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/14737175.2016.1243472","volume":"17","author":"DS Reddy","year":"2017","unstructured":"Reddy DS (2017) Do oral contraceptives increase epileptic seizures? Expert Rev Neurother 17(2):129\u2013134. \n                https:\/\/doi.org\/10.1080\/14737175.2016.1243472","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"208_CR83","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1515\/jpem.2010.161","volume":"23","author":"EO Reiter","year":"2010","unstructured":"Reiter EO, Mauras N, McCormick K, Kulshreshtha B, Amrhein J, De Luca F et al (2010) Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab 23(10):999\u20131009","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"208_CR84","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1055\/s-0038-1673613","volume":"118","author":"NS Roetker","year":"2018","unstructured":"Roetker NS, MacLehose RF, Hoogeveen RC, Ballantyne CM, Basu S, Cushman M, Folsom AR (2018) Prospective study of endogenous hormones and incidence of venous thromboembolism: the atherosclerosis risk in communities study. Thromb Haemost 118(11):1940\u20131950. \n                https:\/\/doi.org\/10.1055\/s-0038-1673613","journal-title":"Thromb Haemost"},{"issue":"4","key":"208_CR85","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1210\/jcem-62-4-670","volume":"62","author":"M Roger","year":"1986","unstructured":"Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M et al (1986) Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. J Clin Endocrinol Metab 62(4):670\u2013677. \n                https:\/\/doi.org\/10.1210\/jcem-62-4-670","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"208_CR86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/cen.13164","volume":"86","author":"J Rohayem","year":"2017","unstructured":"Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M, German Adolescent Hypogonadotropic Hypogonadism Study Group (2017) Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? \u2013 a multicentre prospective study of hCG\/rFSH treatment outcomes during adolescence. Clin Endocrinol 86(1):75\u201387. \n                https:\/\/doi.org\/10.1111\/cen.13164","journal-title":"Clin Endocrinol"},{"issue":"13","key":"208_CR87","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJMoa1005669","volume":"364","author":"JL Ross","year":"2011","unstructured":"Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, Cutler GB Jr (2011) Growth hormone plus childhood low-dose estrogen in Turner\u2019s syndrome. N Engl J Med 364(13):1230\u20131242. \n                https:\/\/doi.org\/10.1056\/NEJMoa1005669","journal-title":"N Engl J Med"},{"issue":"1","key":"208_CR88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-018-0896-5","volume":"19","author":"S Sacco","year":"2018","unstructured":"Sacco S, Merki-Feld GS, \u00c6gidius KL, Bitzer J, Canonico M, Gantenbein AR et al (2018) Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). J Headache Pain 19(1):76. \n                https:\/\/doi.org\/10.1186\/s10194-018-0896-5","journal-title":"J Headache Pain"},{"issue":"1\u20132","key":"208_CR89","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","volume":"61","author":"AE Schindler","year":"2008","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH (2008) Classification and pharmacology of progestins. Maturitas 61(1\u20132):171\u2013180","journal-title":"Maturitas"},{"key":"208_CR90","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000438895","volume":"29","author":"M Schoelwer","year":"2016","unstructured":"Schoelwer M, Eugster EA (2016) Treatment of peripheral precocious puberty. Endocr Dev 29:230\u2013239. \n                https:\/\/doi.org\/10.1159\/000438895","journal-title":"Endocr Dev"},{"issue":"5","key":"208_CR91","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000308172","volume":"73","author":"S Seminara","year":"2010","unstructured":"Seminara S, Nanni L, Generoso M, Mirri S, Leonardi V, Slabadzianiuk T et al (2010) Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty. Horm Res Paediatr 73(5):386\u2013389. \n                https:\/\/doi.org\/10.1159\/000308172","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"208_CR92","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1687-9856-2014-12","volume":"2014","author":"S Shah","year":"2014","unstructured":"Shah S, Forghani N, Durham E, Neely EK (2014) A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. Int J Pediatr Endocrinol 2014(1):12. \n                https:\/\/doi.org\/10.1186\/1687-9856-2014-12","journal-title":"Int J Pediatr Endocrinol"},{"issue":"4","key":"208_CR93","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.contraception.2016.12.006","volume":"95","author":"PN Silva Dos Santos","year":"2017","unstructured":"Silva Dos Santos PN, Madden T, Omvig K, Peipert JF (2017) Changes in body composition in women using long-acting reversible contraception. Contraception 95(4):382\u2013389. \n                https:\/\/doi.org\/10.1016\/j.contraception.2016.12.006","journal-title":"Contraception"},{"issue":"1","key":"208_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1687-9856-2012-26","volume":"2012","author":"EK Sims","year":"2012","unstructured":"Sims EK, Garnett S, Guzman F, Paris F, Sultan C, Eugster EA, Fulvestrant McCune-Albright Study Group (2012) Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome. Int J Pediatr Endocrinol 2012(1):26. \n                https:\/\/doi.org\/10.1186\/1687-9856-2012-26","journal-title":"Int J Pediatr Endocrinol"},{"issue":"9","key":"208_CR95","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/(SICI)1099-081X(199712)18:9<779::AID-BDD64>3.0.CO;2-5","volume":"18","author":"A Sioufi","year":"1997","unstructured":"Sioufi A, Gauducheau N, Pineau V, Marfil F, Jaouen A, Cardot JM et al (1997) Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos 18(9):779\u2013789","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"208_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0010-7824(89)90012-7","volume":"39","author":"R Sitruk-Ware","year":"1989","unstructured":"Sitruk-Ware R (1989) Transdermal delivery of steroids. Contraception 39(1):1\u201320","journal-title":"Contraception"},{"issue":"1","key":"208_CR97","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1210\/jc.2004-1438","volume":"90","author":"L Soriano-Guillen","year":"2005","unstructured":"Soriano-Guillen L, Lahlou N, Chauvet G, Roger M, Chaussain JL, Carel JC (2005) Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty. J Clin Endocrinol Metab 90(1):147\u2013151. \n                https:\/\/doi.org\/10.1210\/jc.2004-1438","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"208_CR98","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1210\/jc.2017-00359","volume":"102","author":"DI Spratt","year":"2017","unstructured":"Spratt DI, Stewart II, Savage C, Craig W, Spack NP, Chandler DW et al (2017) Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: demonstration in female-to-male transgender patients. J Clin Endocrinol Metab 102(7):2349\u20132355. \n                https:\/\/doi.org\/10.1210\/jc.2017-00359","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"208_CR99","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.contraception.2012.12.011","volume":"87","author":"FZ Stanczyk","year":"2013","unstructured":"Stanczyk FZ, Archer DF, Bhavnani BR (2013) Ethinyl estradiol and 17beta-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception 87(6):706\u2013727. \n                https:\/\/doi.org\/10.1016\/j.contraception.2012.12.011","journal-title":"Contraception"},{"issue":"11","key":"208_CR100","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1210\/jc.2011-1449","volume":"96","author":"M Taboada","year":"2011","unstructured":"Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, Mauras N (2011) Pharmacokinetics and pharmacodynamics of oral and transdermal 17beta estradiol in girls with Turner syndrome. J Clin Endocrinol Metab 96(11):3502\u20133510. \n                https:\/\/doi.org\/10.1210\/jc.2011-1449","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"208_CR101","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1507\/endocrj.EJ11-0214","volume":"59","author":"D Tessaris","year":"2012","unstructured":"Tessaris D, Matarazzo P, Mussa A, Tuli G, Verna F, Fiore L, Lala R (2012) Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright syndrome. Endocr J 59(2):111\u2013117","journal-title":"Endocr J"},{"issue":"3","key":"208_CR102","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1517\/17425247.2012.662484","volume":"9","author":"D Teutonico","year":"2012","unstructured":"Teutonico D, Montanari S, Ponchel G (2012) Leuprolide acetate: pharmaceutical use and delivery potentials. Expert Opin Drug Deliv 9(3):343\u2013354. \n                https:\/\/doi.org\/10.1517\/17425247.2012.662484","journal-title":"Expert Opin Drug Deliv"},{"issue":"7","key":"208_CR103","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1210\/jc.2012-4243","volume":"98","author":"L Torres-Santiago","year":"2013","unstructured":"Torres-Santiago L, Mericq V, Taboada M, Unanue N, Klein KO, Singh R et al (2013) Metabolic effects of oral versus transdermal 17beta-estradiol (E(2)): a randomized clinical trial in girls with Turner syndrome. J Clin Endocrinol Metab 98(7):2716\u20132724. \n                https:\/\/doi.org\/10.1210\/jc.2012-4243","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"208_CR104","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1472-6483(10)61927-X","volume":"4","author":"I Trinchard-Lugan","year":"2002","unstructured":"Trinchard-Lugan I, Khan A, Porchet HC, Munafo A (2002) Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reprod Biomed Online 4(2):106\u2013115","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"208_CR105","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1210\/jc.2015-3888","volume":"101","author":"A Trinh","year":"2016","unstructured":"Trinh A, Wong P, Fahey MC, Brown J, Churchyard A, Strauss BJ et al (2016) Musculoskeletal and endocrine health in adults with cerebral palsy: new opportunities for intervention. J Clin Endocrinol Metab 101(3):1190\u20131197. \n                https:\/\/doi.org\/10.1210\/jc.2015-3888","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"208_CR106","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jpag.2016.06.007","volume":"29","author":"KM Usinger","year":"2016","unstructured":"Usinger KM, Gola SB, Weis M, Smaldone A (2016) Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 29(6):659\u2013667. \n                https:\/\/doi.org\/10.1016\/j.jpag.2016.06.007","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"208_CR107","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1210\/jcem.85.3.6437","volume":"85","author":"C Wang","year":"2000","unstructured":"Wang C, Berman N, Longstreth JA, Chuapoco B, Hull L, Steiner B et al (2000) Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center study. J Clin Endocrinol Metab 85(3):964\u2013969. \n                https:\/\/doi.org\/10.1210\/jcem.85.3.6437","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"208_CR108","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1210\/jc.2002-021643","volume":"88","author":"S Wickman","year":"2003","unstructured":"Wickman S, Kajantie E, Dunkel L (2003) Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys. J Clin Endocrinol Metab 88(8):3785\u20133793. \n                https:\/\/doi.org\/10.1210\/jc.2002-021643","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"208_CR109","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","volume":"41","author":"BL Xiao","year":"1990","unstructured":"Xiao BL, Zhou LY, Zhang XL, Jia MC, Luukkainen T, Allonen H (1990) Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device. Contraception 41(4):353\u2013362","journal-title":"Contraception"},{"issue":"3","key":"208_CR110","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.beem.2015.01.002","volume":"29","author":"M Zacharin","year":"2015","unstructured":"Zacharin M (2015) Pubertal induction in hypogonadism: current approaches including use of gonadotrophins. Best Pract Res Clin Endocrinol Metab 29(3):367\u2013383. \n                https:\/\/doi.org\/10.1016\/j.beem.2015.01.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"208_CR111","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.fertnstert.2012.06.022","volume":"98","author":"M Zacharin","year":"2012","unstructured":"Zacharin M, Sabin MA, Nair VV, Dabadghao P (2012) Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril 98(4):836\u2013842. \n                https:\/\/doi.org\/10.1016\/j.fertnstert.2012.06.022","journal-title":"Fertil Steril"},{"issue":"4","key":"208_CR112","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4158\/EP161622.OR","volume":"23","author":"F Zaiem","year":"2017","unstructured":"Zaiem F, Alahdab F, Al Nofal A, Murad MH, Javed A (2017) Oral versus transdermal estrogen in turner syndrome: a systematic review and meta-analysis. Endocr Pract 23(4):408\u2013421. \n                https:\/\/doi.org\/10.4158\/EP161622.OR","journal-title":"Endocr Pract"}],"container-title":["Handbook of Experimental Pharmacology","Pediatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T05:06:43Z","timestamp":1596517603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030504939","9783030504946"],"references-count":112,"URL":"https:\/\/doi.org\/10.1007\/164_2019_208","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"30 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}